A leading Korean based pharmaceutical and healthcare firm reached out to Freyr to get the Regulatory support for various CMC and life cycle management activities. The existing bottlenecks while taking up the project included multiple content reviews in published documents and tight timelines to catch up with.

Through this case study, you can decode how Freyr assisted the client to get through various pre- and post- approval activities and strategies for DMFs, ANDAs. 

Download